About Emerald Therapeutics
Emerald Therapeutics is a company based in San Francisco (United States) founded in 2010 by D J Kleinbaum and Brian Frezza. Emerald Therapeutics has raised $39.5 million across 4 funding rounds from investors including SciFi VC, Founders Fund and Schooner Capital. The company has 77 employees as of December 31, 2022. Emerald Therapeutics operates in a competitive market with competitors including Waters Corporation, Quartzy, Tecan, Synthace and Automata, among others.
- Headquarter San Francisco, United States
- Employees 77 as on 31 Dec, 2022
- Founders D J Kleinbaum, Brian Frezza
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Emerald Therapeutics
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$39.5 M (USD)
in 4 rounds
-
Latest Funding Round
$20 M (USD), Series C
Jun 01, 2015
-
Investors
SciFi VC
& 3 more
-
Employee Count
77
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Emerald Therapeutics
Unlock access to complete
Unlock access to complete
Funding Insights of Emerald Therapeutics
Emerald Therapeutics has successfully raised a total of $39.5M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Emerald Therapeutics
Emerald Therapeutics has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include SciFi VC, Founders Fund and Schooner Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward early-stage consumer-tech startups.
|
Locked | Locked | Locked | |
|
Venture capital investments in technology and defense sectors.
|
Locked | Locked | Locked | |
|
Private equity investments are directed across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Emerald Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Emerald Therapeutics
Investment portfolio details for Emerald Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Emerald Therapeutics
Detailed financials for Emerald Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emerald Therapeutics Comparisons
Peer comparison for Emerald Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Emerald Therapeutics
Emerald Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Waters Corporation, Quartzy, Tecan, Synthace and Automata, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of laboratory management system for researchers and clinicians
|
|
| Locked | Locked | Locked |
Lab management platform for life sciences is offered by Quartzy.
|
|
| Locked | Locked | Locked |
Automated laboratory instruments, robotics, and diagnostic solutions are provided.
|
|
| Locked | Locked | Locked |
SaaS-based laboratory automation software is provided for researchers.
|
|
| Locked | Locked | Locked |
Lab automation robots are provided for life sciences applications.
|
Detailed competitors of Emerald Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emerald Therapeutics
Complete news archive for Emerald Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emerald Therapeutics
Emerald Therapeutics was founded in 2010.
Emerald Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
D J Kleinbaum is the current CEO of Emerald Therapeutics. They have also founded this company.
Emerald Therapeutics is a funded company, having raised a total of $39.5M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Emerald Therapeutics is 77.
Emerald Therapeutics was founded in 2010 in San Francisco, United States, focusing on the life sciences sector. Cloud-based software enables remote access to laboratories via the internet. Automated robotics handle experiment conduction, method design, materials logistics, sample preparation, instrument operation, data acquisition and analysis, troubleshooting, and waste disposal. Operations support research workflows in a distributed manner.
Emerald Therapeutics's top competitors include Tecan, Waters Corporation and Automata.
Emerald Therapeutics has 4 investors. Key investors include SciFi VC, Founders Fund, Schooner Capital, and Max Levchin.